Publicação
Optimizing the Use of Renin‑Angiotensin System Inhibition in Advanced Chronic Kidney Disease
| Resumo: | Chronic kidney disease (CKD) affects millions of people worldwide and is a major public health problem. Renin‑angiotensin system inhibitors are the backbone drugs for preventing CKD progression but have potential side effects, such as hyperkalemia or acute decrease in glomerular filtration rate, which can prevent physicians from starting the drugs, or even lead physicians to stop the drug when already in use in advanced CKD patients. In this review, the principal studies performed on this topic are summarized. |
|---|---|
| Autores principais: | Ferreira, Ana Carina |
| Assunto: | Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors Kidney Failure Chronic Renal Insufficiency Chronic HCC NEF |
| Ano: | 2024 |
| País: | Portugal |
| Tipo de documento: | texto |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Centro Hospitalar de Lisboa Central, EPE (CHLC) |
| Idioma: | inglês |
| Origem: | Repositório do Centro Hospitalar de Lisboa Central, EPE |
| Resumo: | Chronic kidney disease (CKD) affects millions of people worldwide and is a major public health problem. Renin‑angiotensin system inhibitors are the backbone drugs for preventing CKD progression but have potential side effects, such as hyperkalemia or acute decrease in glomerular filtration rate, which can prevent physicians from starting the drugs, or even lead physicians to stop the drug when already in use in advanced CKD patients. In this review, the principal studies performed on this topic are summarized. |
|---|